Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02393248 2023-01-06

Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

Phase 1/2 Terminated

201 enrolled 71 charts

BreastGastrointestinalGynecologicMyeloidPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Myeloproliferative Disorders, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT01920061 2022-09-13

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Phase 1 Completed

110 enrolled 80 charts

Breast

Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms

NCT03012477 2021-11-23

CISPLATIN + AZD-1775 In Breast Cancer

Phase 2 Completed

34 enrolled 9 charts

Breast

Triple-negative Metastatic Breast Cancer

NCT00580333 2021-05-26

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Phase 2 Completed

51 enrolled 7 charts

Breast

Breast Neoplasms

NCT01606748 2019-09-30

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

Phase 2 Completed

35 enrolled 23 charts

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01031446 2018-08-31

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

55 enrolled 12 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01091454 2018-05-08

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

48 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00201760 2017-12-27

Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer

Phase 2 Completed

10 enrolled 9 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00483223 2017-08-25

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

Phase 2 Completed

86 enrolled 14 charts

Breast

Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3, Breast Neoplasms

NCT01918306 2017-06-27

GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer

Phase 1/2 Terminated

11 enrolled 12 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01167192 2016-12-30

Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer

Phase 2 Terminated

10 enrolled 8 charts

Breast

Breast Neoplasms

NCT01194869 2016-10-18

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Phase 2 Terminated

25 enrolled 8 charts

Breast

Breast Neoplasms

NCT00603408 2016-08-19

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

Phase 2 Terminated

5 enrolled 7 charts

Breast

Breast Neoplasms

NCT00930930 2015-05-07

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Phase 2 Completed

145 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Phase 2 Unknown

33 enrolled 5 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00463788 2014-02-13

BALI-1

Phase 2 Completed

181 enrolled 15 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00191789 2010-07-27

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Phase 2 Completed

65 enrolled 13 charts

Breast

Breast Neoplasms

NCT00191854 2010-03-02

Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line

Phase 2 Completed

147 enrolled 17 charts

Breast

Breast Neoplasms

NCT00191815 2009-11-11

Combination Chemotherapy for Metastatic Breast Cancer

Phase 2 Completed

70 enrolled 18 charts

Breast

Breast Neoplasms